Clinical Trial Update: 18F-FDG PET/CT-based Prognostic Model for Predicting Outcome in Patients With Natural Killer/T-cell Lymphoma [NA]

View source ↗

Summary

This clinical trial update describes a study evaluating an 18F-FDG PET/CT-based prognostic model for predicting outcomes in patients with extranodal NK/T-cell l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extranodal Nk T-cell Lymphoma Nasal Type

Snippet

Sponsor: Peking University Cancer Hospital & Institute | Conditions: Lymphoma, Extranodal NK-T-Cell | NA | Status: UNKNOWN